Last --
Change Today 0.00 / 0.00%
Volume 0.0
GALN On Other Exchanges
Symbol
Exchange
SIX Swiss Ex
OTC US
Frankfurt
OTC US
All times are local (Market data is delayed by at least 15 minutes).

galenica ag-reg (GALN) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for GALENICA AG-REG (GALN)

Related News

No related news articles were found.

galenica ag-reg (GALN) Related Businessweek News

No Related Businessweek News Found

galenica ag-reg (GALN) Details

Galenica Ltd. develops, manufactures, and markets pharmaceutical products in Switzerland and internationally. Its Pharma segment offers iron replacement products, including Ferinject/Injectafer, Venofer, and Maltofer; immuno-stimulant products, such as Broncho-Vaxom and Uro-Vaxom; infectious diseases/OTX products, over-the-counter products, and herbal remedies; and synthetic and biotech drugs for use in immunology and the treatment of infectious diseases. This segment also provides products for patients suffering from chronic kidney disease; develops and markets CellCept for various applications involving autoimmune diseases; and markets products manufactured by third parties. The company’s Logistics segment offers pre-wholesale logistics services, including storage and distribution of products, and debt collection services to pharmaceutical and healthcare companies; supplies healthcare products to pharmacies, physicians, drug stores, care homes, and hospitals; and handles and coordinates the purchase, sale, warehousing, and distribution of products for third parties. Its Retail segment operates 483 pharmacies, including 312 own pharmacies and 171 partner pharmacies under the Amavita and Sun Store brands in Switzerland. This segment also operates a chain of 55 own pharmacies in partnership under the Coop Vitality brand; MediService specialty pharmacy that offers medication for the treatment of patients in their own homes; and 160 Winconcept partner pharmacies. The company’s HealthCare Information segment provides master data systems for the healthcare market; and publishes printed and electronic technical information on pharmaceutical products. This segment also maintains databases; offers management solutions under the Triamun brand name; TriaPharm total management software solution for pharmacies; TriaMed software for physicians; and TriaOne non-sector specific ERP solution for retail. Galenica Ltd. was founded in 1927 and is headquartered in Bern, Switzerland.

6,278 Employees
Last Reported Date: 08/12/14
Founded in 1927

galenica ag-reg (GALN) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

galenica ag-reg (GALN) Key Developments

Galenica Ltd. Presents at Jefferies 2014 Global Healthcare Conference: London, Nov-20-2014 11:20 AM

Galenica Ltd. Presents at Jefferies 2014 Global Healthcare Conference: London, Nov-20-2014 11:20 AM. Venue: The Waldorf Hilton, Aldwych, London, United Kingdom.

Galenica Ltd. Presents at UBS Best of Switzerland Conference, Sep-19-2014 10:30 AM

Galenica Ltd. Presents at UBS Best of Switzerland Conference, Sep-19-2014 10:30 AM. Venue: Wolfsberg Conference Center, Ermatingen, Switzerland. Speakers: Jörg Kneubühler, Chief Executive Officer of Galenica Santé, Julien Vignot, Head of Treasury.

Galenica AG Appoints Jorg Kneubuhler as CEO of Galenica Sante Division

Galenica AG has unveiled a new operational management structure with two CEOs who will reportedly manage Vifor Pharma and Galenica Sante divisions. Both CEOs will report directly to the Executive Chairman. The role of CEO Galenica Group is being abolished. The new management structure will enable the different Pharma and Sante business models to develop in an even more focused way, taking into account their individual growth dynamics. The Board of Directors of the Galenica Group has appointed Jorg Kneubuhler as CEO of the Galenica Sante Division. Jorg Kneubuhler will also continue to be CFO of the Galenica Group. The new structure will enter into effect immediately.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GALN:SW SFr.0.00 CHF 0.00

GALN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AMAG Pharmaceuticals Inc $44.17 USD +0.87
Celesio AG €26.35 EUR +0.041
Fresenius Medical Care AG & Co KGaA €60.60 EUR +0.462
Rockwell Medical Inc $8.32 USD +0.075
UDG Healthcare PLC 390.80 GBp +8.70
View Industry Companies
 

Industry Analysis

GALN

Industry Average

Valuation GALN Industry Range
Price/Earnings 16.4x
Price/Sales 1.3x
Price/Book 3.0x
Price/Cash Flow 12.9x
TEV/Sales 1.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GALENICA AG-REG, please visit www.galenica.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.